HK

Hemant Kumar Jindal

Active Director Director DIN 10449658
DIN 10449658 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemant Kumar Jindal

Data last updated:

Hemant Kumar Jindal is a Director at Yuventis Lifesciences Private Limited (since 2024). The company operates in Pharma.

DIN 10449658
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20242024Active

Board colleagues of Hemant Kumar Jindal

NameDINCompanyDesignation
Promila Rani10449657Yuventis Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yuventis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Hemant Kumar Jindal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemant Kumar Jindal

Hemant Kumar Jindal currently holds 1 directorship: Yuventis Lifesciences Private Limited (Director, since 02 Jan 2024).

Hemant Kumar Jindal was first appointed on 02 Jan 2024 as Director at Yuventis Lifesciences Private Limited.

The current boards of Hemant Kumar Jindal's companies include Promila Rani (Yuventis Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available